annual CFF:
$4.76M-$291.88M(-98.39%)Summary
- As of today (July 26, 2025), SWTX annual cash flow from financing activities is $4.76 million, with the most recent change of -$291.88 million (-98.39%) on December 31, 2024.
- During the last 3 years, SWTX annual CFF has risen by +$3.61 million (+311.67%).
Performance
SWTX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
quarterly CFF:
-$10.61M-$11.26M(-1724.66%)Summary
- As of today (July 26, 2025), SWTX quarterly cash flow from financing activities is -$10.61 million, with the most recent change of -$11.26 million (-1724.66%) on March 31, 2025.
- Over the past year, SWTX quarterly CFF has dropped by -$10.06 million (-1821.92%).
Performance
SWTX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CFF:
-$5.29M-$10.06M(-211.15%)Summary
- As of today (July 26, 2025), SWTX TTM cash flow from financing activities is -$5.29 million, with the most recent change of -$10.06 million (-211.15%) on March 31, 2025.
- Over the past year, SWTX TTM CFF has dropped by -$303.23 million (-101.78%).
Performance
SWTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SWTX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.4% | -1821.9% | -101.8% |
| 3 y3 years | +311.7% | -4164.8% | -599.9% |
| 5 y5 years | -98.6% | -10000.0% | -103.1% |
SWTX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.6% | +311.7% | -103.1% | at low | -101.6% | at low |
| 5 y | 5-year | -98.6% | +311.7% | -103.1% | at low | -101.6% | at low |
| alltime | all time | -98.6% | +311.7% | -103.1% | at low | -101.6% | at low |
SWTX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$10.61M(-1724.7%) | -$5.29M(-211.1%) |
| Dec 2024 | $4.76M(-98.4%) | $653.00K(-49.4%) | $4.76M(-98.4%) |
| Sep 2024 | - | $1.29M(-61.7%) | $303.18M(+0.5%) |
| Jun 2024 | - | $3.37M(-710.7%) | $301.65M(+1.2%) |
| Mar 2024 | - | -$552.00K(-100.2%) | $297.94M(+0.4%) |
| Dec 2023 | $296.64M(-12.9%) | $299.07M(<-9900.0%) | $296.64M(<-9900.0%) |
| Sep 2023 | - | -$242.00K(-29.2%) | -$2.13M(-100.6%) |
| Jun 2023 | - | -$342.00K(-81.5%) | $338.34M(-0.1%) |
| Mar 2023 | - | -$1.85M(-720.1%) | $338.59M(-0.6%) |
| Dec 2022 | $340.70M(>+9900.0%) | $298.00K(-99.9%) | $340.70M(+0.0%) |
| Sep 2022 | - | $340.23M(<-9900.0%) | $340.65M(>+9900.0%) |
| Jun 2022 | - | -$88.00K(-133.7%) | $842.00K(-20.5%) |
| Mar 2022 | - | $261.00K(+7.0%) | $1.06M(-8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.16M(-99.6%) | $244.00K(-42.6%) | $1.16M(-99.6%) |
| Sep 2021 | - | $425.00K(+229.5%) | $270.89M(-0.0%) |
| Jun 2021 | - | $129.00K(-64.1%) | $270.89M(+0.0%) |
| Mar 2021 | - | $359.00K(-99.9%) | $270.84M(+0.1%) |
| Dec 2020 | $270.49M(-18.9%) | $269.97M(>+9900.0%) | $270.49M(>+9900.0%) |
| Sep 2020 | - | $428.00K(+448.7%) | $532.00K(-99.7%) |
| Jun 2020 | - | $78.00K(+1200.0%) | $169.84M(+0.0%) |
| Mar 2020 | - | $6000.00(-70.0%) | $169.76M(-49.1%) |
| Dec 2019 | $333.71M(+562.4%) | $20.00K(-100.0%) | $333.71M(+0.0%) |
| Sep 2019 | - | $169.73M(>+9900.0%) | $333.69M(+103.5%) |
| Jun 2019 | - | $0.00(-100.0%) | $163.96M(0.0%) |
| Mar 2019 | - | $163.96M | $163.96M |
| Dec 2018 | $50.38M | - | - |
FAQ
- What is SpringWorks Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for SpringWorks Therapeutics, Inc.?
- What is SpringWorks Therapeutics, Inc. annual CFF year-on-year change?
- What is SpringWorks Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for SpringWorks Therapeutics, Inc.?
- What is SpringWorks Therapeutics, Inc. quarterly CFF year-on-year change?
- What is SpringWorks Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for SpringWorks Therapeutics, Inc.?
- What is SpringWorks Therapeutics, Inc. TTM CFF year-on-year change?
What is SpringWorks Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of SWTX is $4.76M
What is the all time high annual CFF for SpringWorks Therapeutics, Inc.?
SpringWorks Therapeutics, Inc. all-time high annual cash flow from financing activities is $340.70M
What is SpringWorks Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, SWTX annual cash flow from financing activities has changed by -$291.88M (-98.39%)
What is SpringWorks Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of SWTX is -$10.61M
What is the all time high quarterly CFF for SpringWorks Therapeutics, Inc.?
SpringWorks Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $340.23M
What is SpringWorks Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, SWTX quarterly cash flow from financing activities has changed by -$10.06M (-1821.92%)
What is SpringWorks Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of SWTX is -$5.29M
What is the all time high TTM CFF for SpringWorks Therapeutics, Inc.?
SpringWorks Therapeutics, Inc. all-time high TTM cash flow from financing activities is $340.70M
What is SpringWorks Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, SWTX TTM cash flow from financing activities has changed by -$303.23M (-101.78%)